Take action with us now and transform the lives and prospects of women today and for the generations to come.
Advice and support for if your cancer has returned.
As a research-based organisation, it is of paramount importance that there is reliable scientific evidence to support claims made about any cancer treatment, as lives are at stake. While it’s tempting to think that a cancer patient has nothing to lose by trying an alternative treatment, in fact, there are big risks. Taking medications outside of those recommended by your oncologist may have interactions and additional side-effects, so consult a medical professional before taking anything new.
Scientific research requires robust evidence; vital for determining whether or not a potential cancer treatment is actually safe and effective. Publishing this data then allows health organisations and medical professionals to judge the information for themselves and use it for the benefit and safety of their patients.
When an individual shares their story it can transform another person's life.
If you’re considering using cannabis oil, it’s also important to know the risks:
Using cannabis oil as a means to treat or cure cancer is a topic of much online debate and the internet is full of people claiming that it has effectively helped to cure their cancer. We take a closer look at the evidence behind these claims.
After extensive counseling, the patient declined all interventions due to concerns regarding quality of life and treatment toxicity. She elected to pursue alternative therapy and started Laetrile tablets (500 mg orally four times per day) and cannabidiol (CBD) oil (1 drop sublingually each evening) in May 2017. Her Ca-125 level in May 2017 was 46, and after one month on the above regimen, her Ca-125 normalized to 22 ( Fig. 2 ).
Perhaps most provocative is the recent report that 40% of Americans believe that use of CAM is sufficient for the management of cancer (National Cancer Opinion Survey, 2019). In addition, 22% of Americans with a history of a cancer diagnosis and 38% of family caregivers share this belief. However, a recent study evaluated overall survival and adherence to treatment in patients receiving conventional cancer treatment with or without CAM for cancers considered curable. Patients who used CAM had significantly decreased overall survival when compared to those who did not, and also had higher rates of refusal of standard therapy (Johnson et al., 2018). Notably, this risk of death is linked to the refusal of therapy and not to the use of CAM itself. This demonstrates the importance and need for transparent, open discussions with patients regarding current available therapies, expected outcomes, and alternatives that patients may be seeking or have not yet disclosed.
An 81-year-old woman presented to her primary care physician with an umbilical mass that was suspected to be a hernia in March 2017. She was taken to the operating room in April 2017 for planned herniorrhaphy. The surgical findings were notable for a solid, peri-umbilical mass, as well as diffuse intra-abdominal nodularity. Final pathology of the resected umbilical lesion demonstrated a serous carcinoma, likely mullerian primary based on immunohistochemistry staining. Her Ca-125 was found to be elevated at 77.
Cannabidiol (CBD) is a compound naturally derived from the cannabis plant. The anti-cancer effects of CBD have been evaluated predominantly in the laboratory setting. Interestingly, ovarian cancer cell lines express GPR55, a target that is inhibited indirectly by CBD and that plays a role in prostate and ovarian cancer cell proliferation (Piñeiro et al., 2011). Mouse model studies have also demonstrated cannabinoids inhibit tumor cell growth and induce apoptosis in gliomas, lymphomas, prostate, breast, lung, skin, and pancreatic cancer cells (Sarfaraz et al., 2008). Despite this theoretical benefit, there is not clear evidence that it has more or less activity than standard treatments in cancer patients.
Ca-125 trend on treatment.
CT scan May 2017, illustrating a right adnexal mass measuring 5.8 cm × 5.0 cm.
The management of patients with LGSOC remains a challenge, particularly in the advanced stage and recurrent setting. The current standard of care remains platinum and taxane based combination chemotherapy, followed by maintenance hormonal therapy. Unfortunately, patients who progress have limited therapeutic options and are encouraged to consider clinical trials if available, as response rates to chemotherapy in the recurrent setting are less than 5% (Grisham and Iyer, 2018).
Cbd is only any good as a pain killer, some people have been using it for years me included..
Good luck with your treatment and best wishes for the future.
Ovarian cancer and CBD oil
As far as any body knows no tests have been done to check on anything else. Thares also a risk of different side effects maybe some of them bad. Check with oncologist before trying.
I have no personal experience but I know that anyone who is thinking of trying it MUST check with their consultant first. This is to ensure it doesn’t contradict any treatment that the patient is on.
1382 posts since